Sort   by:  
 Page size 
ProteomicsAcetylation site mapping on TULP3
Fig. 2B: Semi-quantitative acetylation level on TULP3 in the presence of either empty pcDNA 3.1(+), Myc-p300, FLAG-PCAF or FLAG-GCN5 following immunoprecipitation.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2020-10-22 | MSV000086358 | MassIVE
ProteomicsIdentification of TULP3 protein interactions
Table S1: Anti-FLAG immunoprecipitation on HEK293T cell lysates stably expressing FLAG-TULP3 .
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2020-10-22 | MSV000086357 | MassIVE
ProteomicsIn-vitro acetylation assay of TULP3
Fig. S1D: An in-vitro assay that identified the acetylation sites on recombinant TULP3 with the addition of recombinant human p300.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2020-10-20 | MSV000086340 | MassIVE
ProteomicsUbiquitin remnant profiling on TULP3
Fig. 5E: An anti-FLAG immunoprecipitation on HEK293T cell lysates stably expressing FLAG-TULP3 for ubiquitination site identification (GlyGly)
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2020-10-21 | MSV000086346 | MassIVE
ProteomicsLabel-free quantification of NMT1 and NMT2 knockout as well as PCLX-001 treated HAP1 cells
HAP1 cells with an NMT1, NMT2, or double knockout (as well as wildtype controls) were prepared by in-gel trypsin digestion and analyzed by LC-MS/MS label-free quantification (data-dependent acquisition). Additionally, HAP1 cells were treated with PCLX-001, an NMT inhibitor, at EC50 and EC90 (as well...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2023-05-10 | MSV000091913 | MassIVE
Sort   by:  
 Page size